See also this year's filing and all EDGAR filings for this company.
PDF Report 0001042074_2020_Cymabay_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001042074, Cymabay Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 202,923,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,409,000 |
| 3 | remainder_Assets | 395,000 |
| 4 | LiabilitiesCurrent | 17,636,000 |
| 5 | LiabilitiesNoncurrent | 1,743,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 21,246,937 |
| 9 | ResearchAndDevelopmentExpense | 176,134,123 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -29,179 |
| 13 | remainder_ComprehensiveNetIncome | 885,210 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 205,727,000 |
| 1 | Liabilities | 19,379,000 |
| 2 | Expenses | 197,381,060 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 186,348,000 |
| 5 | NetIncome | -197,410,239 |
| 6 | ComprehensiveNetIncome | -196,967,634 |
| 7 | BaseVar | 211,700,724 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.86 |
| 9 | EconomicCapitalRatio | 2.93 |
Edgar->Model Mapping
Feature Distribution
Change over Time
